The GLP is committed to full transparency. Download and review our 2019 Annual Report

Glyphosate on trial: Bayer would consider settling all cancer lawsuits on ‘reasonable terms’, as suits now number 18,400

| | July 31, 2019

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Bayer on [July 30] said it would consider settling with U.S. plaintiffs suing over the German group’s Roundup herbicide only on reasonable terms, and if such a move wraps up all cases.

Bayer said the number of U.S. plaintiffs blaming Roundup and other glyphosate-based weedkillers for their cancer continued to rise by 5,000 to 18,400….

Read full, original article: Bayer sees glyphosate settlement only if financially reasonable

Related article:  Genetic Literacy Project’s Top 6 Stories for the Week - May 8, 2017
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend